HOME >> BIOLOGY >> NEWS
Smallpox vaccines

THE claim that Britain's smallpox vaccine is less likely to protect people in the event of a bioterrorist attack than the US version sparked a political row last week. But the US government's top adviser on smallpox has told New Scientist that they are both equally likely to work.

The claim that the British vaccine is inferior was made by Stephen Prior of the Potomac Institute for Policy Studies. He looked at which vaccines were used where, and with what success, during the eradication programmes of the 1960s and 1970s.

Two vaccines were used widely during this time. One was developed by the Lister Institute in Britain, the other by the New York City Board of Health. Last year, as fears grew that terrorists would try a smallpox attack, the US ordered the NYCBH strain from a company called Acambis. This April, Britain ordered the Lister strain from another company, PowderJect.

The British government is already under fire for awarding the contract to PowderJect without putting it out to competitive tender, especially as the head of the company has made contributions to the governing Labour Party. So the media seized on Prior's charges that PowderJect's vaccine may not protect against the smallpox strain most likely to be used by terrorists: India-1967, which was mass-produced by the Soviet Union.

Prior says the Lister strain was used later in the eradication drive, in places where the virus was no longer in circulation, whereas the NYCBH strain was more widely used where smallpox was still endemic, especially in India, where India-1967 was probably circulating. "It would therefore seem logical to have any vaccine-based defence [use] the vaccine strains that exhibited success during the eradication campaign," he concludes.

But DA Henderson of Johns Hopkins University, who led the smallpox eradication drive and is the US's chief smallpox adviser, rejects Prior's claims. He says the Lister strain was used to eliminate the virus
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
7-Aug-2002


Page: 1 2

Related biology news :

1. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
2. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
3. Smallpox vaccination grinds to halt
4. CDC Telebriefing: Smallpox educational activities and West Nile Virus update
5. Inadequate vaccines can help breed more vicious malaria strains
6. Researcher issues caution on live virus vaccines
7. Scientists learn how adjuvant makes vaccines effective
8. Thimerosal, found in childhood vaccines, can increase the risk of autism-like damage in mice
9. Botulinum toxin structure offers clues for vaccines/treatments
10. Gates Foundation commits $82.9 million to develop new tuberculosis vaccines
11. A link between thimerosal and the brain: Can vaccines affect central nervous system function?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
(Date:6/25/2020)... (PRWEB) , ... June 24, 2020 , ... ... cloud-based enterprise software and software-driven clinical data services that accelerate drug development, is ... low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... ... date growth of 40% in 2020, despite many obstacles created as a result ... to increase revenue for its partnered medical practices and medical manufacturers by expanding ...
(Date:7/1/2020)... WESTMINSTER, Colo. (PRWEB) , ... ... ... providers of expert tissue data insights, today announced that the launch of ... PD-L1 results along with data about the tumor microenvironment (TME). , “Flagship’s ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... to develop a vaccine or drug treatment. In an effort to better understand ... publicly released the world’s largest imaging dataset portraying therapeutic compound effects from over ...
(Date:6/28/2020)... (PRWEB) , ... June 26, 2020 , ... ... association representing security solutions providers, today announced its strong opposition to the recently ... bill would impose a blanket ban on most federal use of nearly all ...
Breaking Biology Technology:
Cached News: